We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
(+7%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$104M |
| 2 |
Apple
AAPL
|
+$60.7M |
| 3 |
Amazon
AMZN
|
+$47.5M |
| 4 |
American Express
AXP
|
+$28.7M |
| 5 |
Travelers Companies
TRV
|
+$27.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$28.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$28.1M |
| 3 |
Clorox
CLX
|
+$26.2M |
| 4 |
TJX Companies
TJX
|
+$24.8M |
| 5 |
McKesson
MCK
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.39% |
| 2 | Financials | 11.87% |
| 3 | Technology | 10.68% |
| 4 | Communication Services | 10.67% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Travelers Companies
TRV
$80.6B
| $28.9M | 0.72% |
+248,893
| New | +$27.2M |
|
27
Allstate
ALL
$66.7B
| $28M | 0.7% |
+418,600
| New | +$26.3M |
|
28
Philip Morris
PM
$303B
| $27.9M | 0.7% |
286,189
+143,698
| +101% | +$13.2M |
|
29
Bristol-Myers Squibb
BMY
$127B
| $27.1M | 0.68% |
427,051
+189,587
| +80% | +$12M |
|
30
Estee Lauder
EL
$29B
| $26.9M | 0.67% |
286,494
-57,232
| -17% | -$5.1M |
|
|
MJN
31
DELISTED
Mead Johnson Nutrition Company
MJN
| $26.7M | 0.67% |
315,401
+298,938
| +1,816% | +$22.2M |
|
32
Visa
V
$673B
| $26.3M | 0.66% |
345,591
-219,334
| -39% | -$15.9M |
|
33
Regeneron Pharmaceuticals
REGN
$69.2B
| $25.4M | 0.64% |
70,958
-25,965
| -27% | -$10.7M |
|
34
Starbucks
SBUX
$118B
| $24.4M | 0.61% |
410,766
-397,224
| -49% | -$23.1M |
|
35
Chevron
CVX
$388B
| $24.3M | 0.61% |
256,321
+113,510
| +79% | +$9.93M |
|
36
Alibaba
BABA
$270B
| $24.2M | 0.61% |
307,788
+196,345
| +176% | +$13.8M |
|
37
Emerson Electric
EMR
$82.4B
| $23.9M | 0.6% |
441,734
+167,491
| +61% | +$8.08M |
|
38
Alphabet (Google) Class C
GOOG
$3.9T
| $22.9M | 0.57% |
617,400
-87,120
| -12% | -$3.12M |
|
39
KeyCorp
KEY
$24.3B
| $22.8M | 0.57% |
2,072,618
+574,994
| +38% | +$6.43M |
|
|
SPLS
40
DELISTED
Staples Inc
SPLS
| $22.5M | 0.56% |
2,052,877
+2,020,027
| +6,149% | +$19M |
|
41
CBRE Group
CBRE
$40.8B
| $22.2M | 0.56% |
774,781
+152,581
| +25% | +$4.2M |
|
42
Aflac
AFL
$63.7B
| $22.1M | 0.55% |
+703,906
| New | +$20.9M |
|
|
DFS
43
DELISTED
Discover Financial Services
DFS
| $21.1M | 0.53% |
417,276
-50,507
| -11% | -$2.43M |
|
44
Danaher
DHR
$134B
| $20.4M | 0.51% |
322,398
+93,190
| +41% | +$5.56M |
|
45
NVIDIA
NVDA
$5T
| $20.4M | 0.51% |
23,075,400
-3,064,560
| -12% | -$2.34M |
|
46
SLB Ltd
SLB
$78.1B
| $20.4M | 0.51% |
277,707
+30,847
| +12% | +$2.17M |
|
47
Incyte
INCY
$23.6B
| $19.7M | 0.49% |
273,352
-5,072
| -2% | -$378K |
|
|
CMA
48
DELISTED
Comerica
CMA
| $19.4M | 0.48% |
514,028
+183,895
| +56% | +$6.63M |
|
|
ALXN
49
DELISTED
Alexion Pharmaceuticals
ALXN
| $19M | 0.48% |
+137,394
| New | +$20.2M |
|
50
Baidu
BIDU
$36B
| $18.7M | 0.47% |
+98,730
| New | +$16.8M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2016 Portfolio in Review
As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.
- Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
- Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
- Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
- Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
- Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
- Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
- Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.
Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.